User-friendly interface for quick playback and easy backup via USB or network. Who is the PRN-4011 for?
| Feature | Edaravone (Approved) | NXY-059 (Failed) | | | :--- | :--- | :--- | :--- | | Primary Target | Free radical scavenging | Nitrone-based trapping | Nrf2 activation + mPTP | | CNS Penetration | Moderate | Low | High (1.4:1 ratio) | | Therapeutic Window | < 2 hours | < 4 hours | Targeting > 6 hours | | Route of Admin | IV infusion | IV infusion | Oral bioavailability (60%) | prn-4011
Report any serious or unexpected events related to PRN-4011 to [pharmacovigilance/supervisor/IRB] within 24 hours. User-friendly interface for quick playback and easy backup